ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $2,832,000 | -61.4% | 70,059 | -45.0% | 0.14% | -50.7% |
Q2 2015 | $7,333,000 | +168.4% | 127,412 | +197.0% | 0.28% | +158.7% |
Q1 2015 | $2,732,000 | +832.4% | 42,901 | +803.0% | 0.11% | +445.0% |
Q4 2014 | $293,000 | -68.3% | 4,751 | -82.3% | 0.02% | -52.4% |
Q2 2014 | $924,000 | -72.6% | 26,814 | -65.6% | 0.04% | -82.5% |
Q1 2014 | $3,370,000 | +383.5% | 77,984 | +345.5% | 0.24% | +336.4% |
Q4 2013 | $697,000 | +4.0% | 17,506 | -2.0% | 0.06% | +3.8% |
Q3 2013 | $670,000 | – | 17,858 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |